Clinical Trials on Small Vessel Cerebrovascular Disease
Total 17697 results
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Italy, Spain, Turkey, Brazil, Canada, United Kingdom, France, Poland, Australia, Egypt, Argentina, Denmark
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Australia, France, United Kingdom, Brazil, Canada
-
Amicus TherapeuticsTerminatedFabry DiseaseAustralia, United States, Italy, Spain, Belgium, Turkey, Brazil, Argentina, United Kingdom, Denmark, France, Canada, Egypt
-
University Hospital, CaenUnknown
-
National Institute of Neurological Disorders and...National Institute of Neurological Disorders and Stroke@@@Shire Human Genetic...Completed
-
Genzyme, a Sanofi CompanyCompleted
-
Rigshospitalet, DenmarkCompletedFabry DiseaseDenmark
-
National Institute of Neurological Disorders and...Completed
-
Assistance Publique - Hôpitaux de ParisUnknown
-
First Affiliated Hospital Xi'an Jiaotong UniversityGeneral Hospital of Ningxia Medical University; Second Affiliated Hospital... and other collaboratorsNot yet recruitingCoronary Artery Disease | Hypertension | Arrhythmias, Cardiac | Heart Valve Diseases | Brain Neoplasms | Myocarditis | Cardiomyopathies | Aortic Dissection | Structural Heart Disease | Heart Neoplasms | Ischemic Cerebrovascular Disease | Hemorrhagic Cerebrovascular DiseaseChina
-
Tianjin Huanhu HospitalRecruitingLarge Vessel Occlusion | Endovascular Procedures | Stroke, Acute IschemicChina
-
Tianjin Huanhu HospitalEnrolling by invitationLarge Vessel Occlusion | Endovascular Procedures | Stroke, Acute IschemicChina
-
Children's Hospital of Fudan UniversityNot yet recruiting
-
Westfälische Wilhelms-Universität MünsterChiesi GmbHRecruiting
-
ISU Abxis Co., Ltd.RecruitingFabry DiseaseKorea, Republic of
-
SanofiRecruiting
-
Bio Sidus SARecruiting
-
Amicus TherapeuticsRecruiting
-
University Health Network, TorontoOzmosis Research Inc.Completed
-
4D Molecular TherapeuticsActive, not recruiting
-
Bio Sidus SACompleted
-
TakedaCompleted
-
AVROBIOTerminatedFabry DiseaseUnited States, Australia, Brazil
-
National and Kapodistrian University of AthensCompletedFabry DiseaseGreece
-
Genzyme, a Sanofi CompanyCompleted
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Denmark, Belgium, United Kingdom, Norway, Italy, Czechia
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Spain, United Kingdom, Paraguay
-
Chiesi Farmaceutici S.p.A.Iqvia Pty Ltd; ProtalixCompletedFabry DiseaseUnited States, Belgium, Denmark, Italy, United Kingdom
-
University of UtahGenzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States
-
Amicus TherapeuticsCompletedFabry DiseaseUnited Kingdom, United States
-
Manchester University NHS Foundation TrustNorthern Care Alliance NHS Foundation TrustCompletedFabry DiseaseUnited Kingdom
-
Children's Hospital of Fudan UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Wuhan Union Hospital, China and other collaboratorsWithdrawn
-
ShireCompletedFabry DiseaseCanada, United States
-
ShireCompletedFabry DiseaseUnited States, United Kingdom, Australia, Czechia, Finland, Paraguay, Poland, Slovenia
-
ShireCompleted
-
ShireCompletedFabry DiseaseFinland, Sweden, Germany, Belgium, Czechia, Denmark
-
Amicus TherapeuticsApproved for marketingPhysician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry DiseaseFabry DiseaseUnited States, Australia
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States
-
Amicus TherapeuticsTerminatedFabry DiseaseUnited Kingdom, United States, Australia, Brazil, France
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, United Kingdom
-
Chiayi Christian HospitalSanofiUnknown
-
National Institute of Neurological Disorders and...CompletedFabry DiseaseUnited States
-
Spital LinthUniversity of Zurich; National University, SingaporeUnknown
-
University Hospital, BordeauxUnknown